Solara Active Pharma Sciences has announced the appointment of Arun Kumar Baskaran as its new Chief Financial Officer (CFO). Baskaran assumed his new role in March 2024, bringing to the table a vast expanse of experience and a profound knowledge of corporate finance and business strategy.
Before rising to the position of CFO at Solara, Baskaran played a pivotal role as Vice President of Strategy & FP&A, where he applied his skills in M&A, leadership, problem solving, and business strategy. His tenure at Solara Active Pharma Sciences has been marked by significant contributions to the company’s strategic planning and financial analysis efforts, highlighting his aptitude for steering financial operations towards sustainable growth.
Baskaran’s extensive experience prior to joining Solara includes impactful roles at notable organizations such as Sabi, where he served as Vice President and Chief Commercial Officer, and Rensource Energy, where he was the Head of Commercial & Partnerships. His career has also been enriched by his tenure at Strides Shasun Limited, where he handled M&A transactions and business finance for Generic Partners, further honing his expertise in the financial aspects of the pharmaceutical and energy sectors.
As Solara Active Pharma Sciences continues to set new standards in the API manufacturing industry, Baskaran’s leadership as CFO is anticipated to fortify the company’s financial health, foster strategic investments, and ensure robust financial strategies that align with Solara’s ambitious vision for growth and innovation.
